Angiodynamics (ANGO) Debt to Equity (2011 - 2025)

Angiodynamics has reported Debt to Equity for 15 years, with the latest figure at $0.03 in Q1 2025.

• For the quarter ending Q1 2025, Debt to Equity fell 38.07% year-over-year to $0.03; the trailing twelve-month figure through Feb 2025 stood at $0.03 (down 38.07% YoY), and the FY2024 full-year result was $0.02, down 86.53% from the prior year.
• Debt to Equity for Q1 2025 stood at $0.03, up from $0.03 in the prior quarter.
• The five-year high for Debt to Equity was $0.17 in Q2 2023, with the low at $0.01 in Q3 2023.
• Historically, Debt to Equity has averaged $0.07 across 5 years, with a median of $0.06 in 2021.
• Annual changes were most pronounced in 2021 — Debt to Equity jumped 180.71% — and 2023, when it slumped 92.2%.
• Angiodynamics' Debt to Equity stood at $0.06 in 2021, then surged by 152.48% to $0.15 in 2022, then slumped by 83.97% to $0.02 in 2023, then climbed by 13.51% to $0.03 in 2024, then advanced by 1.29% to $0.03 in 2025.
• The last three Debt to Equity figures came in at $0.03 (Q1 2025), $0.03 (Q4 2024), and $0.02 (Q3 2024), per Business Quant data.